|
Q3 FY2026
As of Sep 30, 2026
|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| CURRENT ASSETS: | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Billed accounts receivable, less allowance for credit losses of $24,384 and $19,708, respectively | ||||||||||||||||||||
| Unbilled accounts receivable, less allowance for credit losses of $2,497 and $1,508, respectively | ||||||||||||||||||||
| Other receivables, less allowance for credit losses of $223 and $325, respectively | ||||||||||||||||||||
| Inventories | ||||||||||||||||||||
| Prepaid expenses and other | ||||||||||||||||||||
| Costs and estimated earnings in excess of billings, less allowance for credit losses of $458 and $255, respectively | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| PROPERTY AND EQUIPMENT, NET | ||||||||||||||||||||
| LEASE RIGHT-OF-USE ASSETS | ||||||||||||||||||||
| GOODWILL | ||||||||||||||||||||
| IDENTIFIABLE INTANGIBLE ASSETS, NET | ||||||||||||||||||||
| DEFERRED TAX ASSETS | ||||||||||||||||||||
| OTHER NONCURRENT ASSETS | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| LIABILITIES AND STOCKHOLDERS' EQUITY | ||||||||||||||||||||
| CURRENT LIABILITIES: | ||||||||||||||||||||
| Current maturities of long-term debt | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Accrued compensation and benefits | ||||||||||||||||||||
| Billings in excess of costs and estimated earnings and deferred revenue | ||||||||||||||||||||
| Accrued self-insurance | ||||||||||||||||||||
| Other current liabilities | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| LONG-TERM DEBT | ||||||||||||||||||||
| LEASE LIABILITIES | ||||||||||||||||||||
| DEFERRED TAX LIABILITIES | ||||||||||||||||||||
| OTHER LONG-TERM LIABILITIES | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| STOCKHOLDERS' EQUITY: | ||||||||||||||||||||
| Common stock, $.01 par, 102,969,912 shares authorized, 41,123,365 and 41,123,365 shares issued, respectively | ||||||||||||||||||||
| Treasury stock, at cost, 6,129,102 and 5,946,145 shares, respectively | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Total stockholders' equity | ||||||||||||||||||||
| Total liabilities and stockholders' equity | ||||||||||||||||||||
Loading...
